Determine in vitro susceptibility to antimicrobial agents for Nocardia spp. and other aerobic actinomycetes.
New York DOH Approval Status
Actively growing Nocardia isolate in pure culture.
Transport sealed container with isolate in pure culture on agar slant. Place each specimen in individually sealed bag.
Mixed cultures or non-viable organisms.
Isolate identification and specimen source required.
Ambient: 1 month; Refrigerated: 2 weeks; Frozen: Unacceptable
Susceptible, intermediate, or resistant.
Susceptibility testing is performed by broth microdilution using custom-made MIC panels and interpreted according to CLSI guidelines.
Laboratory Developed Test (LDT)
The following agents are available for testing: amikacin, amoxicillin/clavulanic acid, cefepime, ceftriaxone, ciprofloxacin, clarithromycin, doxycycline, imipenem, linezolid, minocycline, moxifloxacin, tigecycline, tobramycin, and trimethoprim/sulfamethoxazole. Selective reporting by organism.
An additional processing fee will be billed for all organisms not submitted in pure culture, as indicated in the specimen requirements.
If species identification is not provided, identification will be performed at ARUP. Additional charges apply.
|Component Test Code*||Component Chart Name||LOINC|
- Antimicrobial Susceptibility, Nocardia species
- Nocardia Susceptibility Panel